DbDEMC 2.0: Updated database of differentially expressed miRNAs in human cancers

Nucleic Acids Research

Volumn 45, Issue D1, 2017, Pages D812-D818

  Yang, Zhen ^a   Wu, Liangcai ^b   Wang, Anqiang ^b   Tang, Wei ^c   Zhao, Yi ^d   Zhao, Haitao ^b   Teschendorff, Andrew E ^a,e  

^a MAX PLANCK INSTITUTE   (Germany)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c TIANJIN UNIVERSITY   (China)

^d INSTITUTE OF COMPUTING TECHNOLOGY   (China)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA;

ACCESS TO INFORMATION; ARTICLE; CANCER GENETICS; CANCER RESEARCH; COMPUTER INTERFACE; DATA PROCESSING; DBDEMC 2.0 DATABASE; EXPERIMENTAL STUDY; GENE EXPRESSION PROFILING; GENETIC DATABASE; HMDD DATABASE; INTERNET; MALIGNANT NEOPLASM; MEDICAL DOCUMENTATION; MEDICAL INFORMATION SYSTEM; MIR2DISEASE DATABASE; RNA ANALYSIS; TUMIR DATABASE; BIOLOGY; GENETICS; GENOMICS; HUMAN; NEOPLASM; NUCLEIC ACID DATABASE; PROCEDURES; SEARCH ENGINE; SOFTWARE; WEB BROWSER;

COMPUTATIONAL BIOLOGY; DATABASES, NUCLEIC ACID; GENE EXPRESSION PROFILING; GENOMICS; HUMANS; MICRORNAS; NEOPLASMS; SEARCH ENGINE; SOFTWARE; WEB BROWSER;

EID: 85016160712     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkw1079     Document Type: Article

References (38)

1. Siegel, R., Ma, J., Zou, Z. and Jemal, A. (2014) Cancer statistics, 2014. CA Cancer J. Clin., 64, 9-29.
2. Bartel, D.P. (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116, 281-297.
3. Adams, B.D., Kasinski, A.L. and Slack, F.J. (2014) Aberrant regulation and function of microRNAs in cancer. Curr. Biol, 24, R762-R776.
4. Kozomara, A. and Griffths-Jones, S. (2014)miRBase: annotating high confdence microRNAs using deep sequencing data. Nucleic Acids Res., 42, D68-D73.
5. Hwang, H.W. and Mendell, J.T. (2006) MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer, 94, 776-780.
6. Jovanovic, M. and Hengartner, M.O. (2006) miRNAs and apoptosis: RNAs to die for. Oncogene, 25, 6176-6187.
7. Wienholds, E., Kloosterman, W.P., Miska, E., Alvarez-Saavedra, E., Berezikov, E., de Bruijn, E., Horvitz, H.R., Kauppinen, S. and Plasterk, R.H. (2005) MicroRNA expression in zebrafish embryonic development. Science, 309, 310-311.
8. Shivdasani, R.A. (2006) MicroRNAs: regulators of gene expression and cell differentiation. Blood, 108, 3646-3653.
9. Svoronos, A.A., Engelman, D.M. and Slack, F.J. (2016) OncomiR or tumor suppressor? The duplicity of microRNAs in cancer. Cancer Res., 76, 3666-3670.
10. Lu, J., Getz, G., Miska, E.A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B.L., Mak, R.H., Ferrando, A.A. et al (2005) MicroRNA expression profles classify human cancers. Nature, 435, 834-838.
11. Mansoori, B., Mohammadi, A., Shirjang, S. and Baradaran, B. (2015) Micro-RNAs: the new potential biomarkers in cancer diagnosis, prognosis and cancer therapy. Cell. Mol. Biol. (Noisy-le-grand), 61, 1-10.
12. Bouchie, A. (2013) First microRNA mimic enters clinic. Nat. Biotechnol., 31, 577.
13. Tutar, L., Tutar, E., Ozgur, A. and Tutar, Y (2015) Therapeutic targeting of microRNAs in cancer: future perspectives. Drug Dev. Res., 76, 382-388.
14. Zhou, L., Li, X., Liu, Q., Zhao, F. and Wu, J. (2011) Small RNA transcriptome investigation based on next-generation sequencing technology. J. Genet. Genomics, 38, 505-513.
15. De Cecco, L., Dugo, M., Canevari, S., Daidone, M.G. and Callari, M. (2013) Measuring microRNA expression levels in oncology: from samples to data analysis. Crit. Rev. Oncog, 18, 27'3-287.
16. Yang, Z., Ren, F., Liu, C, He, S., Sun, G, Gao, Q., Yao, L., Zhang, Y, Miao, R., Cao, Y et al. (2010) dbDEMC: a database of differentially expressed miRNAs in human cancers. BMC Genomics, 11(Suppl. 4), S5.
17. Jiang, Q., Wang, Y, Hao, Y, Juan, L., Teng, M., Zhang, X., Li, M., Wang, G and Liu, Y (2009) miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res., 37, D98-D104.
18. Li, Y, Qiu, C, Tu, J., Geng, B., Yang, J., Jiang, T and Cui, Q. (2014) HMDD v2.0: a database for experimentally supported human microRNA and disease associations. Nucleic Acids Res., 42, D1070-D1074.
19. Xie, B., Ding, Q., Han, H. and Wu, D. (2013) miRCancer: a microRNA-cancer association database constructed by text mining on literature. Bioinformatics, 29, 638-644.
20. Dong, L., Luo, M., Wang, F., Zhang, J., Li, T and Yu, J. (2013) TUMIR: an experimentally supported database of microRNA deregulation in various cancers. J. Clin. Bioinforma, 3, 7.
21. Wang, D., Gu, J., Wang, T and Ding, Z. (2014) OncomiRDB: a database for the experimentally verifed oncogenic and tumor-suppressive microRNAs. Bioinformatics, 30, 2237-2238.
22. Ritchie, M.E., Phipson, B., Wu, D., Hu, Y, Law, C.W., Shi, W. and Smyth, GK. (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res., 43, e47.
23. Van Peer, G, Lefever, S., Anckaert, J., Beckers, A., Rihani, A., Van Goethem, A., Volders, PJ., Zeka, F., Ongenaert, M., Mestdagh, P et al. (2014) miRBase Tracker: keeping track of microRNA annotation changes. Database (Oxford), 2015, bau080.
24. Gray, K.A., Yates, B., Seal, R.L., Wright, M.W. and Bruford, E.A. (2015) Genenames.org: the HGNC resources in 2015. Nucleic Acids Res., 43, D1079-D1085.
25. Maglott, D., Ostell, J., Pruitt, K.D. and Tatusova, T (2011) Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res., 39, D52-D57.
26. Yates, A., Akanni, W., Amode, M.R., Barrell, D., Billis, K., Carvalho-Silva, D., Cummins, C, Clapham, P, Fitzgerald, S., Gil, L. et al. (2016) Ensembl 2016. Nucleic Acids Res., 44, D710-D771.
27. Agarwal, V, Bell, GW., Nam, J.W. and Bartel, D.P (2015) Predicting effective microRNA target sites in mammalian mRNAs. Elife, 4, doi:10.7554/eLife.05005.
28. Paraskevopoulou, M.D., Georgakilas, G, Kostoulas, N, Vlachos, I.S., Vergoulis, T, Reczko, M., Filippidis, C, Dalamagas, T and Hatzigeorgiou, A.G (2013) DIANA-microT web server v5.0: service integration into miRNA functional analysis workfows. Nucleic Acids Res., 41, W169-W173.
29. Miranda, K.C, Huynh, T, Tay, Y, Ang, YS., Tam, W.L., Thomson, A.M., Lim, B. and Rigoutsos, I. (2006) A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell, 126, 1203-1217.
30. Krutovskikh, VA. and Herceg, Z. (2010) Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers. Bioessays, 32, 894-904.
31. Singh, R., Ramasubramanian, B., Kanji, S., Chakraborty, A.R., Haque, S.J. and Chakravarti, A. (2016) Circulating microRNAs in cancer: Hope or hype? Cancer Lett., 381, 113-121.
32. He, Y, Lin, J., Kong, D., Huang, M., Xu, C, Kim, T.K., Etheridge, A., Luo, Y, Ding, Y and Wang, K. (2015) Current state of circulating microRNAs as cancer biomarkers. Clin. Chem., 61, 1138-1155.
33. Liu, Z., Zhang, J., Yuan, X., Liu, B., Liu, Y, Li, A., Zhang, Y, Sun, X. and Tuo, S. (2015) Detecting pan-cancer conserved microRNA modules from microRNA expression profles across multiple cancers. Mol. Biosyst., 11, 2227-2237.
34. Lee, E., Ito, K., Zhao, Y, Schadt, E.E., Irie, HY and Zhu, J. (2016) Inferred miRNA activity identifes miRNA-mediated regulatory networks underlying multiple cancers. Bioinformatics, 32, 96-105.
35. Huang, TT, PingY.H., Wang, A.M., Ke, CC, Fang, W.L., Huang, K.H., Lee, H.C, Chi, CW. and Yeh, TS. (2015) The reciprocal regulation loop of Notch2 pathway and miR-23b in controlling gastric carcinogenesis. Oncotarget, 6, 18012-18026.
36. Majid, S., Dar, A.A., Saini, S., Deng, G, Chang, I., Greene, K., Tanaka, Y, Dahiya, R. and Yamamura, S. (2013) MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PLoS One, 8, e67686.
37. Duan, J., Zhang, H., Qu, Y, Deng, T, Huang, D, Liu, R., Zhang, L., Bai, M., Zhou, L., Ying, G et al. (2016) Onco-miR-130 promotes cell proliferation and migration by targeting TGFbetaR2 in gastric cancer. Oncotarget, 7, 44522-44533.
38. Egawa, H., Jingushi, K., Hirono, T, UedaY., Kitae, K., Nakata, W., Fujita, K., Uemura, M., Nonomura, N and Tsujikawa, K. (2016) The miR-130 family promotes cell migration and invasion in bladder cancer through FAK and Akt phosphorylation by regulating PTEN. Sci. Rep., 6, 20574.